|
Importancia del Monitoreo Ambulatorio de la Presion Arterial y el estudio ecocardiografico con carac
18-Verdecchia P, Schillaci G, Zampi I, Gatteschi C, Battistelli M, Bartoccini C, et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993;88:986-92.
19-Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol 2002;40(11):2039-43.
20-Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 1999;152:1855-60.
21-Kuwajima I, Susuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. Disminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 1992;67:1307-11.
22-Verdecchia P, Angeli F. Natural History of Hypertension Subtypes. Circulation 2005;111:1094-6.
23-Koren MJ, Devereux RB, Cesale PN, Savage DD, Larga JH. Relation of ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. An Intern Med 1991;114:345-52.
24-Savage DD, Garridon AR, Kannel WB. The spectrum of left ventricular hypertrophy in a general population sample: The Framinghan Study. Circulation 1987;75(1 Pt 2):126-33.
25-Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrohpy: Prevalence and risk factors. The Framinghan Heart Study. Ann Intern Med 1988;108:7-13.
26-Levy D, Garrison RF, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framinghan Heart Study. N Engl J Med 1990;322:1561-6.
27-Yuda S, Short L, Leano R, Marwick T. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: study of ultrasound tissue characterization and strain. Clinical Science 2002;103:283-93.
28-Bendersky M, Piskorz D, Boccardo D. Cardiopatía hipertensiva. Rev Fed Arg Cardiol 2002;31:321-34.
29-Alfau G. Evaluación ecocardiográfica de la hipertensión arterial y la cardiopatía hipertensiva. En: Batista del Villar G, editor. II Congreso Nacional - V Jornada caribeña de Hipertensión Arterial; 2001 mayo 30 – junio 2; Santo Domingo, República Dominicana. Santo Domingo: Instituto Dominicano de Hipertensión; 2002. pp. 46-54.
30-Martinez M, Sancho T, Armada E, Rubio JM, Antón JL, Torre A, et al. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification. Am J Hypertens 2003;16(7):556-63.
31-Maceira AM, Barba J, Varo N, Beloqui O, Diez J. Ultrasonic Backscatter and Serum Marker of Cardiac Fibrosis in Hypertensives. Hypertension 2002;39:923-8.
32-Kunichika H, Sakai H, Matsuzaki M. Influence of Acute Preload Changes on Cyclic Variation of Ultrasonic Integrated Backscatter in Hypertrophic Left Ventricular Wall. Ultrasound Med Biol 2000;26(2 Suppl):16.
33-Mobarek SK, Richards DR, Percy C, Meza MF, Moreno CA. Ultrasonic Tissue Characterization: Applicability and Sensitivity of Detection of Serial Changes in the Myocardium. J Am Soc Echocardiogr May- June 1996;11:522-60.
34-Di Bello V, Giorgi D, Talini E, Dell’Omo G, Palagi C, Romano MF, et al. Incremental value of ultrasonic tissue characterization (Backscatter) in the evaluation of left ventricular myocardial structure and mechanics in essential arterial hypertension. Circulation 2003;107:74-80.
35-Segovia E, Pérez JE. Caracterización tisular miocárdica por ultrasonidos: Backscatter. Rev Esp Cardiol 1999;52:708-15.
36-Oberti PF. ¿Hipertrofia patológica o fisiológica? Contribución de la evaluación de aspectos estructurales y funcionales miocárdicos por medio de la caracterización y el Doppler tisular. Rev Argent Cardiol 2005;73:83-5.
37-Hoyt RH, Collins SM, Skorton DJ, Ericksen EE, Conyers D. Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter. Circulation 1985;71:740-4.
38-Holland MR, Wallace KD, Miller JG. Potential relationships among myocardial stiffness, the measured level of myocardial backscatter (“image brightness”), and the magnitude of the systematic variation of backscatter (cyclic variation) over the heart cycle. J Am Soc Echocardiogr 2004;17:1131-7.
39-Hita A, Chejtman D, Baratta S, Turri D. La caracterización y el Doppler tisular mejoran el diagnóstico diferencial de la hipertrofia ventricular entre atletas e hipertensos. Rev Argent Cardiol 2005;73:112-8.
40-Milunski MR, Mohr GA, Wear KA, Sobel BE, Miller JG, Wickline SA, et al. Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs. J Am Coll Cardiol 1989;14:462-71.
41-Milunski MR, Mohr GA, Perez JE, Vered Z, Wear KA, Gressler CJ, et al. Ultrasonic tissue characterization with integrated backscatter: acute myocardial ischemia, reperfusion, and stunned myocardium in patients. Circulation 1989;80:491-503.
42-Finch-Johnston AE, Gussak HM, Mobley J, Holland MR, Petrovic O, Perez JE, et al. Cyclic variation of integrated backscatter: dependence of time delay on the echocardiographic view used and the myocardial segment analyzed. J Am Soc Echocardiogr 2000;13(1):9-17.
Autores:
Dra. Aylen Pérez Barreda, especialista de primer grado en Cardiología y en Medicina General Integral.
Dr. Angel Abreu Cruz, especialista de segundo grado en Cardiología, intensivista.
Dra. Angela Castro Arca, especialista de primer grado en Cardiología.
Dr. Miguel Puig Fernández, especialista de primer grado en Medicina Interna, intensivista.
Dra. Madelaine Sarría Castro, especialista de primer grado en bioestadística.
|